Back to the main directory
EarningsReview / Equity
- History rhymes and sometimes repeats by BNP Paribas Exane
- Wynn Macau (1128 HK) by HSBC
- Itaú BBA on ARMAC: In-Line 1Q22, Long Term Is the Name of the Game by Itau
- Itaú BBA on Cury: Stable Results in 1Q22 by Itau
- Q1 22: 8% beat in EBITDA vs consensus by BNP Paribas Exane
- All prepared for a hard landing scenario by BNP Paribas Exane
- Q1 2022 - Good momentum and strong cash flow by BNP Paribas Exane
- INVEST SECURITIES - Pirelli : Un T1 2022 qui confirme un solide « pricing power » - ACHAT , OC 5,9€ vs 6,5€ by Invest Securities
- EQUITA SIM: BPER BANCA (HOLD; Unchanged) - 1Q22 Results by Equita Sim
- ROVI: RDOS. 1T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Norva24 - A strong foundation in a deep market by Danske Bank Equity Research
- Avanza - Short-term pain, long-term gain by Danske Bank Equity Research
- Sandvik - SMMS margins set for fast comeback by Danske Bank Equity Research
- Cary Group - Uncertainty continues to linger by Danske Bank Equity Research
- Eezy - Ready to deliver growth in post-COVID world by Danske Bank Equity Research
- Elisa - Hold: Slight improvement in operating leverage by Nordea
- Terveystalo - Buy/EUR 13.50: Mix impacting short-term profitability by Nordea
- Nordic Semiconductor (Buy, TP: NOK370.00) - Buy on near-term disconnect by DnB Markets
- Mowi (Buy, TP: NOK235.00) - Mixed Q4 trading update by DnB Markets
- Danske Bank (Buy, TP: DKK145.00) - Gradually recovering by DnB Markets
- Axactor (Hold, TP: NOK7.00) - Short-term setbacks by DnB Markets
- Coloplast (Sell, TP: DKK985.00) - Cost inflation starting to hurt by DnB Markets
- Norway Royal Salmon (No_rec, TP: NOK) - Bid for NTS ASA by DnB Markets
- ALK-Abello (Buy, TP: DKK3500.00) - Improved risk/reward after pullback by DnB Markets
- Equinor (Hold, TP: NOK260.00) - Firing on all cylinders by DnB Markets